Literature DB >> 6516426

The pancreatic cancer problem.

E M Livstone, H M Spiro.   

Abstract

Entities:  

Mesh：

Year:  1984        PMID： 6516426     DOI： 10.1007/bf01656019

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  11 in total

Review 1.  Chemotherapy of gastrointestinal cancer.

Authors:  C G Moertel
Journal:  N Engl J Med       Date:  1978-11-09       Impact factor: 91.245

2.  Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-D in advanced measurable pancreatic carcinoma: a Gastrointestinal Tumor Study Group Report.

Authors:  P S Schein; P T Lavin; C G Moertel; S Frytak; R G Hahn; M J O'Connell; R J Reitemeier; J Rubin; A J Schutt; L H Weiland; M Kalser; J Barkin; H Lessner; R Mann-Kaplan; D Redlhammer; M Silverman; M Troner; H O Douglass; S Milliron; J Lokich; J Brooks; J Chaffe; A Like; N Zamcheck; K Ramming; J Bateman; H Spiro; E Livstone; A Knowlton
Journal:  Cancer       Date:  1978-07       Impact factor: 6.860

3.  Intraoperative irradiation for unresectable pancreatic carcinoma.

Authors:  W C Wood; W U Shipley; L L Gunderson; A M Cohen; G L Nardi
Journal:  Cancer       Date:  1982-03-15       Impact factor: 6.860

4.  Ultrasound scanning in patients with clinical suspicion of pancreatic cancer: a retrospective study.

Authors:  D Pollock; K J Taylor
Journal:  Cancer       Date:  1981-03-15       Impact factor: 6.860

5.  A multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma. The Gastrointestinal Tumor Study Group.

Authors: 
Journal:  Ann Surg       Date:  1979-02       Impact factor: 12.969

6.  Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group.

Authors:  C G Moertel; S Frytak; R G Hahn; M J O'Connell; R J Reitemeier; J Rubin; A J Schutt; L H Weiland; D S Childs; M A Holbrook; P T Lavin; E Livstone; H Spiro; A Knowlton; M Kalser; J Barkin; H Lessner; R Mann-Kaplan; K Ramming; H O Douglas; P Thomas; H Nave; J Bateman; J Lokich; J Brooks; J Chaffey; J M Corson; N Zamcheck; J W Novak
Journal:  Cancer       Date:  1981-10-15       Impact factor: 6.860

7.  A strategy against pancreatic cancer.

Authors:  A L Warshaw; J M Richter; D K Podolsky; P R Mueller; J T Ferrucci; W U Shipley
Journal:  J Clin Gastroenterol       Date:  1982-12       Impact factor: 3.062

8.  5-fluorouracil, Adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas.

Authors:  F P Smith; D F Hoth; B Levin; D A Karlin; J S MacDonald; P V Woolley; P S Schein
Journal:  Cancer       Date:  1980-11-01       Impact factor: 6.860

9.  Current trends in the diagnosis and treatment of carcinoma of the pancreas.

Authors:  K W Warren; C Christophi; R Armendariz; S Basu
Journal:  Am J Surg       Date:  1983-06       Impact factor: 2.565

10.  5-Fluorouracil, methyl-CCNU, and radiotherapy with or without testolactone for localized adenocarcinoma of the exocrine pancreas: a Southwest Oncology Group Study.

Authors:  J D McCracken; P Ray; L K Heilbrun; V K Vaitkevicius; J H Saiki; S E Rivkin; A H Rossof; T N Moore
Journal:  Cancer       Date:  1980-10-01       Impact factor: 6.860
View more
  2 in total

1.  A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens.

Authors:  X Fu; F Guadagni; R M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

Review 2.  Carcinoma of the head of the pancreas versus chronic pancreatitis: diagnostic dilemma with significant consequences.

Authors:  Bryce Taylor
Journal:  World J Surg       Date:  2003-10-13       Impact factor: 3.352
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.